Abstract:Abstract:ObjectiveTo investigate the expression and clinical significance of ciRNA ciR7 (CDR1as) in laryngeal squamous cell carcinoma (LSCC), and to analyze the correlation between CDR1as and miR7.MethodsFrom 2011 to 2013,realtime fluorescence quantitative polymerase chain reaction (RTPCR) was used to detect the transcriptional expression levels of CDR1as and miR7 in 61 specimens of laryngeal squamous cell carcinoma and 48 of normal tissues adjacent to tumor.ResultsRTPCR showed that the expression of CDR1as in the LSCC tissues was significantly higher than that in the adjacent tissues (P<0.001), the expression of miR7 in the LSCC tissues was significantly lower than that in the adjacent tissues (P<0.0001), the expression of CDR1as in LSCC tissues from patients with lymph node metastasis was significantly higher than that from those without lymph node metastasis(P<0.01), and the expression level of CDR1as in the LSCC tissues of patients with different TNM stages were significantly different (P<0.05). The difference of 5year survival rate between patients with high expression level of CDR1as in the LSCC tissues and those with low expression level was statistically significant (P=0.02), meanwhile, the expression level of CDR1as was negatively correlated with that of miR7 (r=-0.643, P=0.001).ConclusionsCDR1as is involved in the occurrence and development of LSCC, and its expression can be used as a prognostic indicator of this tumor. CDR1as has a certain correlation with miR7. CDR1as may affect the progression of LSCC by targetedregulating the expression of miR7.